Chemed Stock Forecast
NYSE: CHEHealth CareMedical/Nursing ServicesUSD
Market open · Delayed 15 min · as of Oct 8, 12:49 PM ET
CHE analyst consensus
Consensus (5 analysts)
buy
Avg. price target
$571.60+15.21%
- Strong buy 0
- Buy 2
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Chemed (2026-10-08), 2 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $571.60, with a high estimate of $650.00 and a low estimate of $520.00. The average target implies upside of 15.2% from the current price of $496.16.
The spread between the highest and lowest targets is 25.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CHE.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 2 | 40% |
| Hold | 3 | 60% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $520.00 | +4.81% |
| Average target | $571.60 | +15.21% |
| High target | $650.00 | +31.01% |